{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:03:57Z","timestamp":1784545437078,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Faculty of Medicine and Health Sciences of Norwegian University of Science and Technology \u2013 NTNU"},{"name":"Research Departments of St. Olav University Hospital"},{"name":"joint research council between St. Olav University Hospital and the Faculty of Medicine and Health Sciences"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.drugalcdep.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T03:25:48Z","timestamp":1550028348000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-9690","authenticated-orcid":false,"given":"Katrine","family":"Melby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf W.","family":"Gr\u00e5we","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond O.","family":"Aamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005063.pub3","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008537.pub2","article-title":"Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0015","series-title":"The Ashton Manual","author":"Ashton","year":"2002"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0020","series-title":"The Ashton Manual","author":"Ashton","year":"2002"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/7854_2017_17","article-title":"The multidimensional therapeutic potential of targeting the brain oxytocin system for the treatment of substance use disorders","volume":"35","author":"Bowen","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs. fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0269881111400642","article-title":"Anxiolytic-like effect of oxytocin in the simulated public speaking test","volume":"26","author":"de Oliveira","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0040","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.psyneuen.2012.11.019","article-title":"Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research","volume":"38","author":"Guastella","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","article-title":"Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress","volume":"54","author":"Heinrichs","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1752-4458-4-30","article-title":"Reduction in mental distress among substance users receiving inpatient treatment","volume":"4","author":"Hoxmark","year":"2010","journal-title":"Int. J. Ment. Health Syst."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0055","series-title":"IBM SPSS Statistics for Windows, Version 21.0","author":"IBM Corp","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12671","article-title":"Alcohol withdrawal syndrome: mechanisms, manifestations, and management","volume":"135","author":"Jesse","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1360-0443.1991.tb03098.x","article-title":"Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis","volume":"86","author":"Johnston","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0070","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/npp.2014.12","article-title":"Effects of MDMA and intranasal oxytocin on social and emotional processing","volume":"39","author":"Kirkpatrick","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/FBP.0000000000000258","article-title":"Oxytocin for the treatment of drug and alcohol use disorders","volume":"27","author":"Lee","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0313-z","article-title":"Targeting the oxytocin system to treat addictive disorders: rationale and progress to date","volume":"30","author":"Lee","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/alcalc\/agx077","article-title":"Oxytocin genotype moderates the impact of social support on psychiatric distress in alcohol-dependent patients","volume":"53","author":"Love","year":"2018","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10673220903523615","article-title":"The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans","volume":"18","author":"Macdonald","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2014.01.025","article-title":"Oxytocin\u2019s role in anxiety: a critical appraisal","volume":"1580","author":"MacDonald","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0100","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.psyneuen.2011.02.015","article-title":"A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research","volume":"36","author":"MacDonald","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2017.04.032","article-title":"Emerging pharmacotherapies for alcohol use disorder","volume":"122","author":"Mason","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yhbeh.2011.12.001","article-title":"Breaking the loop: oxytocin as a potential treatment for drug addiction","volume":"61","author":"McGregor","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.2007.128322","article-title":"The alcohol withdrawal syndrome","volume":"79","author":"McKeon","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","article-title":"Identification and management of alcohol withdrawal syndrome","volume":"75","author":"Mirijello","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/ADM.0000000000000213","article-title":"Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder","volume":"10","author":"Mitchell","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopsych.2015.06.004","article-title":"Oxytocin in general anxiety and social fear: a translational approach","volume":"79","author":"Neumann","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0135","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","article-title":"Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice","volume":"38","author":"Neumann","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1530-0277.2012.01958.x","article-title":"Intranasal oxytocin blocks alcohol withdrawal in human subjects","volume":"37","author":"Pedersen","year":"2013","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cns.12489","article-title":"Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French Alcohol Society, issued in partnership with the European Federation of Addiction Societies","volume":"22","author":"Rolland","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers\u2019 reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/15622975.2016.1246752","article-title":"Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision","volume":"18","author":"Soyka","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08039480310000932","article-title":"Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36)","volume":"57","author":"Strand","year":"2003","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.psyneuen.2016.09.018","article-title":"Oxytocin receptor gene variation rs53576 and alcohol abuse in a longitudinal population representative study","volume":"74","author":"Vaht","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neubiorev.2017.04.017","article-title":"The correlation between central and peripheral oxytocin concentrations: a systematic review and meta-analysis","volume":"78","author":"Valstad","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biopsych.2015.06.016","article-title":"Statistical and methodological considerations for the interpretation of intranasal oxytocin studies","volume":"79","author":"Walum","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.01.003_bib0185","series-title":"Management of Substance Abuse Fact Sheet 2012","author":"WHO","year":"2012"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T10:25:52Z","timestamp":1560507952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":37,"alternative-id":["S0376871619300493"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.003","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}